ICOSL+ plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonist

Journal: Science Translational Medicine

Published: 2020-10-07

DOI: 10.1126/scitranslmed.aay4799

Affiliations: 4

Authors: 27

Go to article
Institutions Share
Alpine Immune Sciences, United States of America (USA) 0.56
Indiana University (IU), United States of America (USA) 0.35
University of Minnesota (UMN), United States of America (USA) 0.07
Medical University of South Carolina (MUSC), United States of America (USA) 0.02

Return